Yüklüyor......
Examining reporting and representation of patients with cancer in COVID‐19 clinical trials
BACKGROUND: Patients with cancer are particularly vulnerable in the current COVID‐19 pandemic. Emerging evidence suggests that patients with a cancer diagnosis are three times more likely to die from COVID‐19 compared to non‐cancer patients. Due to these observed risks, it is critical that emerging...
Kaydedildi:
| Yayımlandı: | Cancer Rep (Hoboken) |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley and Sons Inc.
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7995191/ https://ncbi.nlm.nih.gov/pubmed/33621447 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cnr2.1355 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|